Adrian Senderowicz, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 27,000 shares at $7.20 ($194K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Scheduled sale ($194k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2023-06-15 | $93K | — | Filing → |
| PBYI | SELL | 2022-06-21 | $147K | — | Filing → |
| PBYI | SELL | 2021-06-15 | $916K | — | Filing → |